Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Nutraceuticals as new treatment approaches for oral cancer: II. Green tea extracts and resveratrol.

Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M.

Oral Oncol. 2013 Jun;49(6):502-6. doi: 10.1016/j.oraloncology.2013.02.011. Epub 2013 Mar 27. Review.

PMID:
23541947
2.
3.

Chemoprevention of oral cancer by green tea.

Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, Schuster GS.

Gen Dent. 2002 Mar-Apr;50(2):140-6.

PMID:
12004708
4.

Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin.

Zlotogorski A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M.

Oral Oncol. 2013 Mar;49(3):187-91. doi: 10.1016/j.oraloncology.2012.09.015. Epub 2012 Oct 30. Review.

PMID:
23116961
5.

[Nutraceuticals in the combat against oral cancer].

Zlotogorski-Hurvitz A, Dayan A, Dayan D, Chaushu G, Salo T, Vered M.

Refuat Hapeh Vehashinayim (1993). 2014 Apr;31(2):8-13, 84. Hebrew.

PMID:
25252466
6.

Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis.

Mereles D, Buss SJ, Hardt SE, Hunstein W, Katus HA.

Clin Res Cardiol. 2010 Aug;99(8):483-90. doi: 10.1007/s00392-010-0142-x. Epub 2010 Mar 10.

PMID:
20221615
7.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
8.

Green tea: prevention and treatment of cancer by nutraceuticals.

Béliveau R, Gingras D.

Lancet. 2004 Sep 18-24;364(9439):1021-2. No abstract available.

PMID:
15380952
9.

In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.

Weisburg JH, Weissman DB, Sedaghat T, Babich H.

Basic Clin Pharmacol Toxicol. 2004 Oct;95(4):191-200.

10.

Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.

Lee SC, Chan WK, Lee TW, Lam WH, Wang X, Chan TH, Wong YC.

Nutr Cancer. 2008;60(4):483-91. doi: 10.1080/01635580801947674.

PMID:
18584482
11.

The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.

Liu X, Zhang DY, Zhang W, Zhao X, Yuan C, Ye F.

Nutr Cancer. 2011;63(3):466-75. doi: 10.1080/01635581.2011.532901.

PMID:
21391127
12.

Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.

[No authors listed]

J Cell Biochem Suppl. 1996;26:236-57. No abstract available.

PMID:
9154181
13.

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.

Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, Lee CY, Jao HY, Chen MY, Yang JS.

Oncol Rep. 2012 Nov;28(5):1799-807. doi: 10.3892/or.2012.1991. Epub 2012 Aug 24.

PMID:
22923287
14.

Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.

Kale A, Gawande S, Kotwal S, Netke S, Roomi W, Ivanov V, Niedzwiecki A, Rath M.

Phytother Res. 2010 Jan;24 Suppl 1:S48-55. doi: 10.1002/ptr.2899. Erratum in: Phytother Res. 2010 Apr;24(4):632.

PMID:
19585479
15.

New cancer treatment strategy using combination of green tea catechins and anticancer drugs.

Suganuma M, Saha A, Fujiki H.

Cancer Sci. 2011 Feb;102(2):317-23. doi: 10.1111/j.1349-7006.2010.01805.x. Epub 2010 Dec 30. Review.

16.

Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.

Kürbitz C, Heise D, Redmer T, Goumas F, Arlt A, Lemke J, Rimbach G, Kalthoff H, Trauzold A.

Cancer Sci. 2011 Apr;102(4):728-34. doi: 10.1111/j.1349-7006.2011.01870.x. Epub 2011 Feb 24.

17.

Green tea extract-patents and diversity of uses.

Saito ST, Gosmann G, Pungartnik C, Brendel M.

Recent Pat Food Nutr Agric. 2009 Nov;1(3):203-15. Review.

PMID:
20653541
18.
19.

Nutraceuticals as anti-angiogenic agents: hopes and reality.

Dulak J.

J Physiol Pharmacol. 2005 Mar;56 Suppl 1:51-67. Review.

20.

Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.

Stuart EC, Scandlyn MJ, Rosengren RJ.

Life Sci. 2006 Nov 17;79(25):2329-36. Epub 2006 Aug 5. Review.

PMID:
16945390

Supplemental Content

Support Center